Immunoregulatory and antimicrobial effects of nitrogen oxides

Proceedings of the American Thoracic Society

Volumn 3, Issue 2, 2006, Pages 161-165

  Mannick, Joan B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Bacteria; Inhaled nitric oxide; Viruses

Indexed keywords

NITRIC OXIDE; NITROGEN OXIDE;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; CONFERENCE PAPER; DRUG TRANSPORT; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INTESTINE ABSORPTION; INTESTINE ISCHEMIA; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BACTERIAL INFECTIONS; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; NITRIC OXIDE;

EID: 33645533784     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200505-048BG     Document Type: Conference Paper

References (67)

1. Luchsinger BP, Rich EN, Gow AJ, Williams EM, Stamler JS, Singel DJ. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the subunits. Proc Natl Acad Sci USA 2003;100:461-466.
2. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999;96:9027-9032.
3. Robinson JM, Lancaster JR Jr. Hemoglobin-mediated, hypoxia-induced vasodilation via nitric oxide: mechanism(s) and physiologic versus pathophysiologic relevance. Am J Respir Cell Mol Biol 2005;32:257-261.
4. Gow AJ. Nitric oxide, hemoglobin, and hypoxic vasodilation. Am J Respir Cell Mol Biol 2005;32:479-482.
5. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, Kubes P. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998;101:2497-2505.
6. Kubes P, Payne D, Grisham MB, Jourd-Heuil D, Fox-Robichaud A. Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs. Am J Physiol 1999;277:H676-H682.
7. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusioninduced intestinal mucosal permeability.Am J Physiol 1993;265:G189-G195.
8. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994;24:980-984.
9. Ianaro A, O'Donnell CA, Di Rosa M, Liew FY. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 1994;82:370-375.
10. Chang RH, Feng MH, Liu WH, Lai MZ. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 1997;90:364-369.
11. Berendji D, Kolb-Bachofen V, Meyer KL, Grapenthin O, Weber H, Wahn V, Kroncke KD. Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 1997;405:37-41.
12. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-257.
13. Kermarrec N, Chollet-Martin S, Beloucif S, Faivre V, Gougerot-Pocidalo MA, Payen DM. Alveolar neutrophil oxidative burst and 2 integrin expression in experimental acute pulmonary inflammation are not modified by inhaled nitric oxide. Shock 1998;10:129-134.
14. Jean D, Maitre B, Tankovic J, Meignan M, Adnot S, Brun-Buisson C, Harf A, Delclaux C. Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance. Crit Care Med 2002;30:442-447.
15. ras. J Biol Chem 1995;270:7017-7020.
16. ras: structural basis for the nitric oxide-p21ras interaction. J Biol Chem 1997;272:4323-4326.
17. Williams JG, Pappu K, Campbell SL. Structural and biochemical studies of p21Ras S-nitrosylation and nitric oxide-mediated guanine nucleotide exchange. Proc Natl Acad Sci USA 2003;100:6376-6381.
18. Heo J, Campbell SL. Mechanism of p21Ras S-nitrosylation and kinetics of nitric oxide-mediated guanine nucleotide exchange. Biochemistry 2004;43:2314-2322.
19. Janssen YM, Soultanakis R, Steece K, Heerdt E, Singh RJ, Joseph J, Kalyanaraman B. Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells. Am J Physiol 1998;275:L1100-L1109.
20. Davis DW, Weidner DA, Holian A, McConkey DJ. Nitric oxidedependent activation of p53 suppresses bleomycin-induced apoptosis in the lung. J Exp Med 2000;192:857-869.
21. Rudkowski JC, Barreiro E, Harfouche R, Goldberg P, Kishta O, D'Orleans-Juste P, Labonte J, Lesur O, Hussain SN. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L793-L800.
22. Howlett CE, Hutchison JS, Veinot JP, Chiu A, Merchant P, Fliss H. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol 1999;277:L596-L605.
23. Yamashita H, Akamine S, Sumida Y, Inoue M, Sawada T, Nagayasu T, Oka T. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann Thorac Surg 2004;78:292-297.
24. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res 1996;24:2236-2242.
25. Marshall HE, Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-κB. J Biol Chem 2002;277:34223-34228.
26. Marshall HE, Stamler JS. Inhibition of NF-κB by S-nitrosylation. Biochemistry 2001;40:1688-1693.
27. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, Janssen-Heininger YM. Nitric oxide represses inhibitory κB kinase through S-nitrosylation. Proc Natl Acad Sci USA 2004;101:8945-8950.
28. Messmer UK, Brune B. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem J 1996;319:299-305.
29. Glockzin S, von Knethen A, Scheffner M, Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 1999;274:19581-19586.
30. Tamatani M, Ogawa S, Niitsu Y, Tohyama M. Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J Neurochem 1998;71:1588-1596.
31. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005;7:665-674.
32. Schonhoff CM, Gaston B, Mannick JB. Nitrosylation of cytochrome c during apoptosis. J Biol Chem 2003;278:18265-18270.
33. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darley-Usmar VM, Anderson PG. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000;275:20474-20479.
34. Manderscheid M, Messmer UK, Franzen R, Pfeilschifter J. Regulation of inhibitor of apoptosis expression by nitric oxide and cytokines: relation to apoptosis induction in rat mesangial cells and RAW 264.7 macrophages. J Am Soc Nephrol 2001;12:1151-1163.
35. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997;185:601-607.
36. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-31148.
37. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, Stamler JS. Fas-induced caspase denitrosylation. Science 1999;284:651-654.
38. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 2002;4:743-749.
39. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272:1402-1411.
40. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995;95:1884-1890.
41. Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
42. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol 1999;277:H1849-H1856.
43. Ross GA, Oishi P, Azakie A, Fratz S, Fitzgerald RK, Johengen MJ, Harmon C, Hendricks-Munoz K, Xu J, Black SM, et al. Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: implications for rebound hypertension. Am J Physiol Lung Cell Mol Physiol 2005;288:L27-L35.
44. Weinberger B, Fakhrzadeh L, Heck DE, Laskin JD, Gardner CR, Laskin DL. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am J Respir Crit Care Med 1998;158:931-938.
45. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004;2:820-832.
46. Fang FC. Host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity [perspectives series]. J Clin Invest 1997;99:2818-2825.
47. Pacelli R, Wink DA, Cook JA, Krishna MC, DeGraff W, Friedman N, Tsokos M, Samuni A, Mitchell JB. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 1995;182:1469-1479.
48. Stevanin TM, Ioannidis N, Mills CE, Kim SO, Hughes MN, Poole RK. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J Biol Chem 2000;275:35868-35875.
49. Flint DH, Tuminello JF, Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 1993;268:22369-22376.
50. Keyer K, Imlay JA. Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci USA 1996;93:13635-13640.
51. Schapiro JM, Libby SJ, Fang FC. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci USA 2003;100:8496-8501.
52. Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 1991;179:442-448.
53. Padalko E, Ohnishi T, Matsushita K, Sun H, Fox-Talbot K, Bao C, BaldwinWMIII, Lowenstein CJ. Peroxynitrite inhibition of coxsackievirus infection by prevention of viral RNA entry. Proc Natl Acad Sci USA 2004;101:11731-11736.
54. Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadl C, Lowenstein JM, Lowenstein CJ. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999;10:21-28.
55. Cao W, Baniecki ML, McGrath WJ, Bao C, Deming CB, Rade JJ, Lowenstein CJ, Mangel WF. Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo. FASEB J 2003;17:2345-2346.
56. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-1146.
57. Gao X, Tajima M, Sairenji T. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. Virology 1999;258:375-381.
58. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996;183:1501-1514.
59. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997;94:5243-5248.
60. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996;93:2448-2453.
61. Gomes MS, Florido M, Pais TF, Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 1999;162:6734-6739.
62. Fujii S, Akaike T, Maeda H. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology 1999;256:203-212.
63. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K Jr, Kelly KM, Smith TC, Small RJ. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004;291:1603-1609.
64. Webert KE, Vanderzwan J, Duggan M, Scott JA, McCormack DG, Lewis JF, Mehta S. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Crit Care Med 2000;28:2397-2405.
65. Long R, Light B, Talbot JA. Mycobacteriocidal action of exogenous nitric oxide. Antimicrob Agents Chemother 1999;43:403-405.
66. Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998;160:1796-1803.
67. Long R, Jones R, Talbot J, Mayers I, Barrie J, Hoskinson M, Light B. Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother 2005;49:1209-1212.